KEROS THERAPEUTICS IN
60.22
08-October-24 10:41:40
15 minutes delayed
Stocks
+0.10
+0.17%
Today's range
59.95 - 61.00
ISIN
N/A
Source
NASDAQ
-
12 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
28 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Second Quarter 2024 Financial Results
07 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Leadership Updates
17 Jun 2024 16:01:02 By Nasdaq GlobeNewswire
-
17 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
04 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
03 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
28 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
14 May 2024 10:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
08 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
05 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress
29 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock
09 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
03 Jan 2024 21:29:25 By Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Proposed Public Offering of Common Stock
03 Jan 2024 16:05:39 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Develop KER-065 for the Treatment of Obesity
03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
11 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >